chevron_left
Is Indian Pharma Ready for the next big leap?
Speakers
With global market pressures intensifying and supply chains continuing to shift, India’s pharmaceutical industry is preparing for a major inflection point. The evolving landscape — from rising demand for complex generics and specialty APIs to the need for higher regulatory alignment and advanced manufacturing capabilities — is poised to reshape India’s competitive position globally. These changes may redefine growth trajectories for pharma manufacturers, CDMOs and innovators, bringing both significant opportunities and new operational challenges.
In this webinar, our panel of experts will discuss the likely impacts of this transformation on India’s pharma ecosystem, including:
- How global expectations are shifting and what this means for India’s role in complex generics, APIs and biologics
- Where technology and innovation are accelerating, including digital manufacturing, automation and advanced process development
- How CDMOs and manufacturers can strengthen their global competitiveness amid rising quality and compliance demands
- Which capabilities will matter most as global customers reassess their sourcing and partnership strategies
- How investment trends, talent gaps and emerging business models could shape India’s next phase of growth
